SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment

SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment

SARS-CoV-2 nasopharyngeal shedding contributes to the spread of the COVID-19 epidemic. Among 3271 COVID-19 patients treated at the Hospital University Institute Méditerranée Infection, Marseille, France from 3 March to 27 April 2020, tested at least twice by qRT-PCR, the median SARS-CoV-2 nasopharyn...

Full description

Bibliographic Details
Main Authors: Michel Drancourt, Sébastien Cortaredona, Cléa Melenotte, Sophie Amrane, Carole Eldin, Bernard La Scola, Philippe Parola, Matthieu Million, Jean-Christophe Lagier, Didier Raoult, Philippe Colson
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Viruses
Subjects:
SARS-CoV-2
COVID-19
viral persistence
culture
qRT-PCR
hydroxychloroquine
Online Access:https://www.mdpi.com/1999-4915/13/5/890

Internet

https://www.mdpi.com/1999-4915/13/5/890

Similar Items